[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368871-105":59,"doc-detail-368871-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","protocol-for-iterative-in-vivo-selection-of-highly-metastatic-ovarian-cancer-cell-populations-and-metastasis-modeling-in-mice","Protocol for iterative in vivo selection of highly metastatic ovarian cancer cell populations and metastasis modeling in mice","","Ovarian cancer metastasis remains poorly explained in its molecular basis, despite clinical evidence that it proceeds through multiple pathways. The protocol describes an iterative in vivo workflow for selecting highly metastatic cancer cell populations and building mouse metastasis models. It covers inoculation of ES-2-GFP-Luc, longitudinal monitoring of tumor growth and visceral spread, isolation and culture of tumor-derived derivatives, reinoculation with ES-2-MC1-Hep to generate ES-2-MC2-Hep, and evaluation of metastatic colonization efficiency. The method supports mechanistic studies of distant gynecological metastasis and downstream biomarker and therapeutic investigations.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/protocol-for-iterative-in-vivo-selection-of-highly-metastatic-ovarian-cancer-cell-populations-and-metastasis-modeling-in-mice/368871/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/protocol-for-iterative-in-vivo-selection-of-highly-metastatic-ovarian-cancer-cell-populations-and-metastasis-modeling-in-mice/368871.png","ImageObject",300,407,{"name":92,"@type":93},"Aldword","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-26","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of this protocol?","Question",{"text":112,"@type":113},"To iteratively select highly metastatic ovarian cancer cell populations and to establish mouse models for studying metastasis. The protocol also enables mechanistic investigations of distant metastasis in gynecological cancers.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How are tumor growth and visceral spread monitored?",{"text":117,"@type":113},"After inoculation of ES-2-GFP-Luc, tumor growth and visceral spread are monitored over time. The protocol uses bioluminescence approaches based on the labeled cells to track progression.",{"name":119,"@type":110,"acceptedAnswer":120},"What steps are used to establish ES-2-MC2-Hep and evaluate metastasis?",{"text":121,"@type":113},"Tumor-derived derivatives are isolated and cultured, then reinoculated with ES-2-MC1-Hep to establish ES-2-MC2-Hep. Metastatic colonization efficiency is then assessed to quantify metastatic ability.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368871,1790245964,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},2336478940917,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","ll  \nOPEN ACCESS  \nProtocol  \nProtocol for iterative in vivo selection of highly metastatic ovarian cancer cell populations and metastasis modeling in mice  \nThe molecular basis underlying ovarian cancers’ multi-route metastasis remains poorly defined. This protocol details iterative in vivo selection of highly metastatic cancer cell populations and metastasis modeling in ovarian cancer. We outline steps for inoculation of ES-2-GFP-Luc, monitoring tumor growth and visceral spread, isolation and culture of tumor-derived derivatives, reinoculation of ES-2-MC1-Hep to establish ES-2-MC2-Hep, and assessment of metastatic colonization efficiency. This protocol enables mechanistic studies of distant metastasis in gynecological cancers.  \nPublisher’s note: Undertaking any experimental protocol requires adherence to local institutional guidelines for laboratory safety and ethics.  \nYuqi Wang (王煜棋), Mangze Hu (胡鋩泽), Yilong Zou (邹贻龙)  \n[wangyuqi@westlake.edu](wangyuqi@westlake.edu). cn (Y.W.)  \n[zouyilong@westlake.edu](zouyilong@westlake.edu). cn (Y.Z.)  \nHighlights  \nSteps for monitoring tumor growth and visceral spreading of ES-2-GFP-Luc and its derivatives  \nProcedures for isolation and culture of metastatic tumor derivative cell lines  \nSteps for assessment of metastatic colonization efficiency of ES-2-MC2-Hep  \nWang et al. , STAR Protocols 6 , 104095  \nDecember 19, 2025 © 2025 The Author(s) . Published by Elsevier Inc.  \n[https://doi.org/10.1016/j](https://doi.org/10.1016/j). xpro.2025.104095  \nll  \nOPEN ACCESS  \nProtocol  \nProtocol for iterative in vivo selection of highly metastatic ovarian cancer cell populations and metastasis modeling in mice  \nYuqi Wang (王煜棋),1,2,4,* Mangze Hu (胡鋩泽),1,3 and Yilong Zou (邹贻龙)1,2,5,*  \n1Westlake Four-Dimensional Dynamic Metabolomics (Meta4D) Laboratory, Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang 310024, China  \n2School of Life Sciences, Westlake University, Hangzhou, Zhejiang 310024, China  \n3School of Medicine, Westlake University, Hangzhou, Zhejiang 310024, China  \n4Technical contact  \n5Lead contact  \n*[Correspondence:](Correspondence: wangyuqi@westlake.edu.cn)[ wangyuqi@westlake.edu.cn](Correspondence: wangyuqi@westlake.edu.cn) (Y.W.), [zouyilong@westlake.edu.cn](zouyilong@westlake.edu.cn) (Y.Z.) [https://doi.org/10.1016/j.xpro.2025.104095](https://doi.org/10.1016/j.xpro.2025.104095)  \nSUMMARY  \nThe molecular basis underlying ovarian cancers’ multi-route metastasis remains poorly defined. This protocol details iterative in vivo selection of highly metastatic cancer cell populations and metastasis modeling in ovarian cancer. We outline steps for inoculation of ES-2-GFP-Luc, monitoring tumor growth and visceral spread, isolation and culture of tumor-derived derivatives, reinoculation of ES- 2-MC1-Hep to establish ES-2-MC2-Hep, and assessment of metastatic colonization efficiency. This protocol enables mechanistic studies of distant metastasis in gynecological cancers.  \nFor complete details on the use and execution of this protocol, please refer to  \nWang et al.1  \nBEFORE YOU BEGIN  \nOvarian cancer metastasis presents a formidable challenge, as most patients exhibit widespread disease at the time of diagnosis.2 Clinical observations indicate that ovarian cancer metastasizes through multiple complex routes, including peritoneal, hematogenous, and lymphatic pathways.3 Key challenges in elucidating the mechanisms underlying metastasis include limited access to tissues from diverse metastatic sites and the lack of appropriate animal models that faithfully and efficiently recapitulate the clinical features of ovarian cancer metastasis. Herein, we establish a de novo metastatic mouse model that captures the major processes of clinical ovarian cancer metastasis, providing a valuable tool for investigating the mechanisms underlying ovarian cancer metastasis with precision.1  \nThis protocol provides a detailed description for the development ofa mouse model for ovarian cance","cbCaije91HTvAchH","https://ap.wps.com/l/cbCaije91HTvAchH","pdf",13444253,12,"English","# Summary\n# Before You Begin\n## Clinical background and model rationale\n## Key materials\n# Protocol Overview\n## Inoculation and monitoring\n## Isolation and culture of derivatives\n## Reinoculation to establish ES-2-MC2-Hep\n## Assessment of metastatic colonization efficiency\n# Construction of ES-2-GFP-Luc cell line\n## Vector cloning and lentiviral production\n## ES-2 infection and flow sorting\n## In vitro bioluminescence imaging","[{\"question\":\"What is the main goal of this protocol?\",\"answer\":\"To iteratively select highly metastatic ovarian cancer cell populations and to establish mouse models for studying metastasis. The protocol also enables mechanistic investigations of distant metastasis in gynecological cancers.\"},{\"question\":\"How are tumor growth and visceral spread monitored?\",\"answer\":\"After inoculation of ES-2-GFP-Luc, tumor growth and visceral spread are monitored over time. The protocol uses bioluminescence approaches based on the labeled cells to track progression.\"},{\"question\":\"What steps are used to establish ES-2-MC2-Hep and evaluate metastasis?\",\"answer\":\"Tumor-derived derivatives are isolated and cultured, then reinoculated with ES-2-MC1-Hep to establish ES-2-MC2-Hep. Metastatic colonization efficiency is then assessed to quantify metastatic ability.\"}]","Protocol for iterative in vivo selection of highly metastatic ovarian cancer cell populations and metastasis modeling in mice | PDF",1790179017,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c920f28c26b431f102d80512bde0a95e.webp",983,1276,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0c72c7f26e79b6e75f732396420b72ed.webp",982,1275,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bcfbf2fae708eab7ca0d1e883155b9c1.webp",981,1273,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c3cd4a053260f83c30f56742b6a6c3c0.webp",980,1272]